Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The programme is now online. Search for sessions at Heart Failure 2017
Expand the reach of your research: submit your late-breaking science to Heart Failure and World Congress in Acute Heart Failure.
Late-breaking science submission services are now open
Review the submission rules and guidelines
Submission deadline Wednesday 08 March 2017
There will be three oral sessions dedicated to late-breaking science at Heart Failure 2017, where presenters from around the world will share the very latest results of their trials. Each presentation will be followed by a review from an expert in the field. Be there to hear about the latest developments in heart failure. Other late-breaking science abstracts accepted will be displayed in the Clinical Forum.
Late-Breaking Clinical Trial - Reserved for first presentations of the primary endpoint(s) of a novel clinical trial
Clinical Trial Update -Reserved for presentations of new data or secondary analysis of a trial where the primary data have been presented previously
Registry - Reserved for presentations of new Registry or new data / analyses from a registry. Data not previously presented
Basic and Translational Hot Line - Reserved for late submission of important findings in Basic and Translational Cardiovascular Science
With more than 70 submissions to select from, the late-breaking science sessions at Heart Failure 2016 presented the most recent updates in the field.
Slides and videos are accessible to HFA Silver & Gold Members and Fellows of the HFA. More information about congress ressources.
Looking for more content from Heart Failure 2016 ?
Watch HFA News: video highlights from heart failure congresses
© 2017 European Society of Cardiology. All rights reserved